Gonadotropin-Releasing HormoneHormone AntagonistsOvulation InductionPregnancy RateOvarian Hyperstimulation SyndromeFertilization in VitroReceptors, LHRHFertility Agents, FemaleFollicle Stimulating HormoneLuteinizing HormoneTriptorelin PamoateFollicle Stimulating Hormone, HumanBuserelinLuteal PhaseChorionic GonadotropinOocyte RetrievalPregnancySperm Injections, IntracytoplasmicLeuprolideGonadotropinsEstradiolEmbryo ImplantationOocyte DonationReproductive TechniquesFollicle Stimulating Hormone, beta SubunitEmbryo TransferFollicular PhaseReproductive Techniques, AssistedInfertility, FemaleProgesteronePituitary GlandAdenomyosisPituitary Hormone-Releasing HormonesTestosteroneLuteinizing Hormone, beta SubunitOvarian FolliclePregnancy OutcomeOligopeptidesInsemination, ArtificialOocytesFertility AgentsMenotropinsOvulationOvaryDose-Response Relationship, DrugNafarelinCallithrixTestisGonadotropins, PituitaryEndometriumInhibinsPolycystic Ovary SyndromeRats, Sprague-DawleyDopamine AntagonistsExcitatory Amino Acid AntagonistsNeurokinin-1 Receptor AntagonistsFluoroimmunoassayNarcotic AntagonistsRecombinant ProteinsHistamine H2 AntagonistsInterleukin 1 Receptor Antagonist ProteinContraceptives, OralClinical ProtocolsMuscarinic AntagonistsFertilizationPregnancy, MultipleInfertilityGABA AntagonistsFollicular FluidDrug Administration ScheduleAbortion, SpontaneousCorpus LuteumSpermatogenesisPiperidinesHistamine H1 AntagonistsPurinergic P1 Receptor AntagonistsControlled Clinical Trials as TopicTreatment OutcomeProspective StudiesHistamine AntagonistsClomipheneNicotinic AntagonistsAdenosine A2 Receptor AntagonistsEmbryo, MammalianTime FactorsAdrenergic alpha-1 Receptor AntagonistsKisspeptinsPurinergic P2 Receptor AntagonistsMenstrual CycleRNA, MessengerBlastocystCells, CulturedCryopreservationSheepEstrogensSerotonin 5-HT3 Receptor AntagonistsSerotonin 5-HT2 Receptor AntagonistsRats, WistarHypothalamusAdenosine A1 Receptor Antagonists